Teamwork Financial Advisors, LLC Novo Cure LTD Transaction History

Teamwork Financial Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$75.08 - $121.99 $128,987 - $209,578	-1,718 Closed	0 $0
Q3 2021 Oct 13, 2021	SELL	$116.17 - $194.55 $124,882 - $209,141	-1,075 Reduced 38.49%	1,718 $200,000
Q2 2021 Jul 13, 2021	SELL	$130.4 - $225.58 $38,859 - $67,222	-298 Reduced 9.64%	2,793 $620,000
Q1 2021 Apr 12, 2021	SELL	$124.11 - $190.17 $846,057 - $1.3 Million	-6,817 Reduced 68.8%	3,091 $409,000
Q4 2020 Feb 08, 2021	BUY	$112.16 - $174.14 $1.11 Million - $1.73 Million	9,908 New	9,908 $1.71 Million
Q3 2020 Oct 15, 2020	SELL	$58.05 - $111.31 $208,863 - $400,493	-3,598 Closed	0 $0
Q2 2020 Jul 13, 2020	BUY	$57.2 - $74.41 $205,805 - $267,727	3,598 New	3,598 $213,000

272

77.2M

751K

293K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.64B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Teamwork Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Teamwork Financial Advisors, LLC with notifications on news.